FDA Investigator: Arindam Dasgupta
- Arindam Dasgupta first started conducting FDA inspections in 2009, with the last inspection in 2023. Over that time, Arindam Dasgupta has conducted 26 inspections at 23 companies across 23 sites.
Get Arindam Dasgupta's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Semler Research Center Private, Bangalore | Oct 2015
Available Now - $199
Arindam Dasgupta
Human Drug Form 483
FDA 483 Daicel Chiral Technologies (India) Private Limited, Shamirpet | 2023
Out-of-stock
Arindam Dasgupta
Human Drugs Form 483
FDA 483 Agada Biosciences Corp, Halifax | 2020
Out-of-stock
Arindam Dasgupta
Human Drug Form 483
FDA 483 Micro Therapeutic Research Labs Pvt. Ltd, Chennai | 2017
Out-of-stock
Arindam Dasgupta
Human Drug Form 483
FDA 483 Micro Therapeutic Research Labs Pvt. Ltd, Chennai | 2017
Out-of-stock
Arindam Dasgupta
Human Drug Form 483
FDA 483 Pra International-early Development Services, Assen | 2013
Out-of-stock
Arindam Dasgupta
Human Drug Form 483
Co-Investigators (15)
- Gajendiran Mahadevan, FDA Investigator
- Dawn C. Olenjack, FDA Investigator
- Jeanne J. Thai, FDA Investigator
- Craig A. Garmendia, FDA Investigator
- Ruben C. Ayala, FDA Investigator
- Matthew C. Watson, FDA Investigator
- Mohsen Rajabi Abhari, FDA Investigator
- Rajabi Abhari, Mohsen, FDA Investigator
- Young M. Choi, FDA Investigator
- Jennifer C. Adams, FDA Investigator
- Dipesh K. Shah, FDA Investigator
- Daniel J. Roberts, FDA Investigator
- Rochelle B. Young, FDA Investigator
- Comyar Shoghi, FDA Investigator
- Marion W. Nadeau, FDA Investigator